The global adalimumab drugs market is poised for substantial growth as the demand for targeted therapies continues to rise worldwide. Adalimumab, a monoclonal antibody used to treat various inflammatory conditions, has gained significant attention in the pharmaceutical industry due to its efficacy and broad therapeutic application. As we move into the forecast period of 2024-2032, the...